Cost-effectiveness of guidelines for insertion of inferior vena cava filters in high-risk trauma patients

Journal of Vascular Surgery

Volumn 52, Issue 6, 2010, Pages

  Spangler, Emily L ^a   Dillavou, Ellen D ^b   Smith, Kenneth J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; WARFARIN;

ADULT; ANTICOAGULATION; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INFERIOR CAVA VEIN; LUNG EMBOLISM; PRACTICE GUIDELINE; PRIORITY JOURNAL; VEIN INSUFFICIENCY; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

EID: 78650208986     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.06.152     Document Type: Article

References (62)

1. S.R. Shackford, J.W. Davis, P. Hollingsworth-Fridlund, N.S. Brewer, D.B. Hoyt, and R.C. Mackersie Venous thromboembolism in patients with major trauma Am J Surg 159 1990 365 369
2. M.M. Knudson, F.R. Lewis, A. Clinton, K. Atkinson, and J. Megerman Prevention of venous thromboembolism in trauma patients J Trauma 37 1994 480 487
3. G.A. Burns, S.M. Cohn, R.J. Frumento, L.C. Degutis, and L. Hammers Prospective ultrasound evaluation of venous thrombosis in high-risk trauma patients J Trauma 35 1993 405 408
4. J.W. Dennis, S. Menawat, J. Von Thron, W.F. Fallon Jr, G.O. Vinsant, and L.M. Laneve Efficacy of deep venous thrombosis prophylaxis in trauma patients and identification of high-risk groups J Trauma 35 1993 132 138
5. C. Kearon, S.R. Kahn, G. Agnelli, S. Goldhaber, G.E. Raskob, and A.J. Comerota Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 6 Suppl 2008 454 545S
6. W.H. Geerts, D. Bergqvist, G.F. Pineo, J.A. Heit, C.M. Samama, and M.R. Lassen Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 6 Suppl 2008 381S 453S
7. F.B. Rogers, M.D. Cipolle, G. Velmahos, G. Rozycki, and F.A. Luchette Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group J Trauma 53 2002 142 164
8. K.J. Brasel, D.C. Borgstrom, and J.A. Weigelt Cost-effective prevention of pulmonary embolus in high-risk trauma patients J Trauma 42 1997 456 462
9. E. Arias United States life tables, 2004 Nat Vital Stat Rep 2007 56
10. S. Khansarinia, J.W. Dennis, H.C. Veldenz, J.L. Butcher, and L. Hartland Prophylactic Greenfield filter placement in selected high-risk trauma patients J Vasc Surg 22 1995 231 236
11. H. Decousus, A. Leizorovicz, F. Parent, Y. Page, B. Tardy, and P. Girard A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis N Engl J Med 338 1998 409 416
12. D.A. Spain, J.D. Richardson, H.C.J. Polk, T.M. Bergamini, M.A. Wilson, and F.B. Miller Venous thromboembolism in the high-risk trauma patient: do risks justify aggressive screening and prophylaxis? J Trauma 42 1997 463 469
13. J.F. Golob Jr, M.J. Sando, J.C. Kan, C.J. Yowler, M.A. Malangoni, and J.A. Claridge Therapeutic anticoagulation in the trauma patient: is it safe? Surgery 144 2008 591 597
14. T.B. Kinney Update on inferior vena cava filters J Vasc Interv Radiol 14 2003 425 440
15. D. Rosenthal, E.D. Wellons, S.M. Hancock, and A.B. Burkett Retrievability of the Gnther Tulip vena cava filter after dwell times longer than 180 days in patients with multiple trauma J Endovasc Ther 14 2007 406 410
16. N.N. Kirilcuk, E.J. Herget, R.A. Dicker, D.A. Spain, J.C. Hellinger, and S.I. Brundage Are temporary inferior vena cava filters really temporary? Am J Surg 190 2005 864 870
17. J. Neuerburg, R. Gnther, D. Vorwerk, R.F. Dondelinger, H. Jger, and K.J. Lackner Results of a multicenter study of the retrievable Tulip vena cava filter: early clinical experience Cardiovasc Intervent Radiol 20 1997 10 16
18. M.M. Knudson, J.A. Collins, S.B. Goodman, and D.W. McCrory Thromboembolism following multiple trauma J Trauma 32 1992 2 11
19. M.M. Knudson, D.G. Ikossi, L. Khaw, D. Morabito, and L.S. Speetzen Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank Ann Surg 240 2004 490 498
20. W.H. Geerts, R.M. Jay, K.I. Code, E. Chen, J.P. Szalai, and E.A. Saibil A Comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma N Engl J Med 335 1996 701 707
21. U. Linsenmaier, J. Rieger, F. Schenk, C. Rock, E. Mangel, and K. Pfeifer Indications, management, and complications of temporary inferior vena cava filters Cardiovasc Intervent Radiol 21 1998 464 469
22. F.B. Rogers, G. Strindberg, S.R. Shackford, T.M. Osler, C.S. Morris, and M.A. Ricci Five-year follow-up of prophylactic vena cava filters in high-risk trauma patients Arch Surg 133 1998 406 412
23. C. Meier, I.S. Keller, R. Pfiffner, L. Labler, O. Trentz, and T. Pfammatter Early experience with the retrievable OptEase vena cava filter in high-risk trauma patients Eur J Vasc Endovasc Surg 32 2006 589 595
24. J.H.J. Patton, T.C. Fabian, M.A. Croce, G. Minard, F.E. Pritchard, and K.A. Kudsk Prophylactic Greenfield filters: acute complications and long-term follow-up J Trauma 41 1996 231 237
25. R.J. Winchell, D.B. Hoyt, J.C. Walsh, R.K. Simons, and A. Eastman Risk factors associated with pulmonary embolism despite routine prophylaxis: implications for improved protection J Trauma 37 1994 600 606
26. P.J. Offner, A. Hawkes, R. Madayag, F. Seale, and C. Maines The role of temporary inferior vena cava filters in critically ill surgical patients Arch Surg 138 2003 591 595
27. W.S. Hoff, B.A. Hoey, G.A. Wainwright, J.F. Reed, D.S. Ball, and M. Ringold Early experience with retrievable inferior vena cava filters in high-risk trauma patients J Am Coll Surg 199 2004 869 874
28. C.S. Morris, F.B. Rogers, K.E. Najarian, A.D. Bhave, and S.R. Shackford Current trends in vena caval filtration with the introduction of a retrievable filter at a level I trauma center J Trauma 57 2004 32 36
29. S.F. Millward, V.L. Oliva, S.D. Bell, D.A. Valenti, P. Rasuli, and M. Asch Gunther Tulip retrievable vena cava filter: results from the registry of the Canadian Interventional Radiology Association J Vasc Intervent Radiol 12 2001 1053 1058
30. D.J. Schultz, K.J. Brasel, L. Washington, L.R. Goodman, R.R. Quickel, and R.J. Lipchick Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients J Trauma 56 2004 727 733
31. D. Rosenthal, E.D. Wellons, A.B. Levitt, F.W. Shuler, R.E. O'Conner, and V.J. Henderson Role of prophylactic temporary inferior vena cava filters placed at the ICU bedside under intravascular ultrasound guidance in patients with multiple trauma J Vasc Surg 40 2004 958 964
32. E.M. Langan III, R.S. Miller, W.J. Casey III, C.G. Carsten III, R.M. Graham, and S.M. Taylor Prophylactic inferior vena cava filters in trauma patients at high risk: follow-up examination and risk/benefit assessment J Vasc Surg 30 1999 484 490
33. M.B. Streiff Vena caval filters: a comprehensive review Blood 95 2000 3669 3677
34. R.C. Lam, R.L. Bush, P.H. Lin, and A.B. Lumsden Early technical and clinical results with retrievable inferior vena caval filters Vascular 12 2004 233 237
35. The PREPIC Study Group Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: The PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study Circulation 112 2005 416 422
36. W.O. McKinley, A.B. Jackson, D.D. Cardenas, and M.J. DeVivo Long-term medical complications after traumatic spinal cord injury: a regional model systems analysis Arch Phys Med Rehabil 80 1999 1402 1410
37. A.L. McMurtry, J.T. Owings, J.T. Anderson, F.D. Battistella, and R. Gosselin Increased use of prophylactic vena cava filters in trauma patients failed to decrease overall incidence of pulmonary embolism J Am Coll Surg 189 1999 314 320
38. L.J. Greenfield, and M.C. Proctor Recurrent thromboembolism in patients with vena cava filters J Vasc Surg 33 2001 510 514
39. N. Labropoulos, T. Waggoner, W. Sammis, S. Samali, and P.J. Pappas The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms J Vasc Surg 48 2008 407 412
40. Agency for Healthcare Research and Quality HCUPnet: national and regional estimates on hospital use for all patients from the HCUP Nationwide Inpatient Sample (NIS) 2007 http://hcupnet.ahrq.gov/ Accessed: Jun 25, 2009
41. Centers for Medicare & Medicaid Services Physician fee schedule look-up 2007 http://www.cms.hhs.gov/PfsLookup/ Accessed: Jun 30, 2009
42. Centers for Medicare & Medicaid Services 2007 Clinical diagnostic laboratory fee schedule 2007 http://www.cms.hhs.gov/ClinicalLabFeeSched/http:// www.cms.hhs.gov/apps/ama/license.asp?file=/ClinicalLabFeeSched/downloads/07clab. zip Accessed: Jun 30, 2009
43. Centers for Medicare & Medicaid Services Durable medical equipment, prosthetics/orthotics & supplies fee schedules 2007 http://www.cms.hhs.gov/ DMEPOSFeeSched/downloads/d07-jan.zip Accessed: Jun 30, 2009
44. L. Murray Red Book 2007: Pharmacy's fundamental reference (red book drug topics) 2007 Thomson Healthcare Montvale, NJ
45. J.W. Olin, K.M. Beusterien, M.B. Childs, C. Seavey, L. McHugh, and R.I. Griffiths Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study Vasc Med 4 1999 1 7
46. Bureau of Labor Statistics Real earnings in December 2007 2008 http://www.bls.gov/news.release/History/realer.txt Accessed: Jan 29, 2010
47. D. Aujesky, K.J. Smith, J. Cornuz, and M.S. Roberts Cost-effectiveness of low-molecular-weight heparin for secondary prophylaxis of cancer-related venous thromboembolism Thromb Haemost 93 2005 592 599
48. Center for the Evaluation of Value and Risk in Health The cost-effectiveness analysis registry 2009 https://research.tufts-nemc.org/cear/ default.aspx
49. Q. Chau, S.B. Cantor, E. Caramel, M. Hicks, D. Kurtin, and T. Grover Cost-effectiveness of the bird's nest filter for preventing pulmonary embolism among patients with malignant brain tumors and deep venous thrombosis of the lower extremities Support Care Cancer 11 2003 795 799
50. B.J. d'Othe, S. Faintuch, A.W. Reedy, C.F. Nickerson, and M.P. Rosen Retrievable versus permanent caval filter procedures: when are they cost-effective for interventional radiology? J Vasc Intervent Radiol 19 2008 384 392
51. R.P. Gonzalez, M. Cohen, P. Bosarge, J. Ryan, and C. Rodning Prophylactic inferior vena cava filter insertion for trauma: intensive care unit versus operating room Am Surg 72 2006 213 216
52. C.R. Nunn, D. Neuzil, T. Naslund, J.G. Bass, J.M. Jenkins, and R. Pierce Cost-effective method for bedside insertion of vena caval filters in trauma patients J Trauma 43 1997 752 758
53. M.R. Gold, P. Franks, K.I. McCoy, and D.G. Fryback Toward consistency in cost-utility analyses: using national measures to create condition-specific values Med Care 36 1998 778 792
54. T.O. Tengs, and A. Wallace One thousand health-related quality-of-life estimates Med Care 38 2000 583 637
55. P. Haentjens, K. De Groote, and L. Annemans Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement A cost-utility analysis Arch Orthop Trauma Surg 124 2004 507 517
56. R.S. Duriseti, R.D. Shachter, and M.L. Brandeau Value of quantitative D-dimer assays in identifying pulmonary embolism: implications from a sequential decision model Acad Emerg Med 13 2006 755 766
57. D.J. Perlroth, G.D. Sanders, and M.K. Gould Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism Arch Intern Med 167 2007 74 80
58. D. Aujesky, K.J. Smith, J. Cornuz, and M.S. Roberts Cost-effectiveness of low-molecular-weight heparin for secondary prophylaxis of cancer-related venous thromboembolism Thromb Haemost 93 2005 592 599
59. F.P. Sarasin, and M.H. Eckman Management and prevention of thromboembolic events in patients with cancer-related hypercoagulable states: a risky business J Gen Intern Med 8 1993 476 486
60. D. Aujesky, K.J. Smith, J. Cornuz, and M.S. Roberts Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism Chest 128 2005 1601 1610
61. M.F. Botteman, J. Caprini, J.M. Stephens, V. Nadipelli, C.F. Bell, and C.L. Pashos Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States Clin Ther 24 2002 1960 1986
62. M.K. Gould, A.D. Dembitzer, G.D. Sanders, and A.M. Garber Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis: a cost-effectiveness analysis Ann Intern Med 130 1999 789 799